Upgrade to SI Premium - Free Trial

BMO Capital Reiterates Outperform on Johnson & Johnson (JNJ) Following 2Q Report

July 20, 2016 10:39 AM
BMO Capital reiterated an Outperform rating and $132.00 price target on Johnson & Johnson (NYSE: JNJ) following the company's 2Q ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View

Next Articles